Get involved

Claim

Opening the claim…

Reports of serious acute pancreatitis of any cause are not detectably more frequent on GLP-1 receptor agonists in these trials (229 among 93,765 participants against 173 among 67,544; ratio 1.13, 95% CI 0.92 to 1.39, p = 0.26). This cannot test the hazard ratio of 2.46 the VA atlas reported for drug-induced acute pancreatitis: if only that subtype rose by that factor, all pancreatitis would pass the trials' upper limit only if the subtype made up more than 27% of cases on placebo. · sciencejournal.ai